Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study
C9ORF72
Genetic epidemiology
DOI:
10.1159/000525091
Publication Date:
2022-05-16T21:00:32Z
AUTHORS (28)
ABSTRACT
<b><i>Background:</i></b> Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons. In Europe, disease-causing genetic variants have been identified in 40–70% of familial ALS patients and approximately 5% sporadic patients. Norway, the contribution to has not yet studied. light potential development personalized medicine, knowledge causes population becoming increasingly important. The present study provides clinical data on Norwegian population-based cohort. <b><i>Methods:</i></b> Blood samples information from were obtained at all 17 neurological departments throughout Norway during 2-year period. Genetic analysis involved expansion <i>C9orf72</i> exome sequencing targeting 30 known ALS-linked genes. classified using genotype-phenotype correlations bioinformatics tools. <b><i>Results:</i></b> A total 279 included study. Of these, 11.5% had one or several family members affected by ALS, whereas 88.5% no history ALS. cause was 31 individuals (11.1%), among which 18 (58.1%) 13 (41.9%) sporadic. most common (6.8%), 8 11 Pathogenic likely pathogenic <i>SOD1</i> <i>TBK1</i> 10 2 cases. expansions dominated Northern Central regions, South-Eastern region. <b><i>Conclusion:</i></b> study, we gene both Restricting only cases would miss more than 40 percent those with variant, indicating need for as well.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (13)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....